Hypertension - Lecture 2 ( A1 blocker, A2 agonist, Beta Blockers) Flashcards
a1 stimulation results in….
vasoconstriction (reflex bradycardia)
Bladder sphincter contraction
Reduced Lipolysis
a2 stimulation results in….
decreased pre-synaptic NE release (reduced sympathetic outflow)
A1 blockers MOA
selectively block a1 receptors on smooth muscle cells of peripheral vasculature
Lowers BP via vasodilation, decrease PVR
Doxazosin (Cardura) Dose and Frequency
1-8mg, daily
Orthostasis…
when stand up BP drops but doesn’t go back up = dizziness
A1 Blockers Clinical considerations
No benefit in prevention of MI or CHD
“Last line”
A1 Blocker special considerations
2nd line agent in men with BPH
improves urine flow and decrease frequency with some drop in BP
ADE of A1 blocker
Orthostatic hypotension 1st dose syncope Dizziness Reflex tachycardia Peripheral Edema Sexual Dysfunction
a2 agonist MOA
stimulate a2 presynaptic receptors in the brain
increase inhibitory neuron acitivty decrease sympathetic outflow
Lower BP primarily via decrease PVR
Clonidine (Catapress) Dose and Frequency
0.1-0.8 mg, BID
Clonidine (Catapress - TTS) Dose and Frequency
0.1-0.3 mg, Weekly
Benefits of TTS
decreased rebound HTP with abrupt withdrawal
reduces side effects
A2 agonist Clinical considerations
Not 1st line
Avoid in pt with HF
A2 agonist possible indications
Resistant HTN (Clonidine) Pregnancy (Methyldopa)
ADE of A2 agonist
Significant CNS ADE Orthostatic Hypertension Dry mouth Depression Rebound HTN w/ abrupt stop
B1 Location
Heart
B2 Location
Lungs and Periphery
B1 receptor stimulation….
increase HR
increase Renin Secretion
B2 receptor stimulation…..
Smooth muscle relaxation
peripheral vasodilation
Skeletal muscle stimulation
Glycogenolysis & gluconeogenesis